Cite
HARVARD Citation
D'Urzo, A. et al. (n.d.). P236 Superior lung function with once-daily QVA149 translates into improvements in patient-reported breathlessness compared with placebo and tiotropium in COPD patients: the BLAZE study. Thorax. p. A184. [Online].